Estrogen addition to progesterone for luteal phase support in cycles stimulated with GnRH analogues and gonadotrophins for IVF: a systematic review and meta-analysis.

Full Abstract

BACKGROUND:
The purpose of the present systematic review and meta-analysis was to examine whether the probability of pregnancy is increased by adding estrogen to progesterone for luteal phase support in patients treated by in vitro fertilization (IVF).

METHODS:
A literature search covering MEDLINE, EMBASE, CENTRAL, meeting proceedings and reference lists of published articles was performed to identify relevant RCTs. Data were extracted for meta-analysis yielding pooled relative risks (RR) and 95% confidence intervals (CI). Sensitivity analyses by including studies with pseudo-randomization or unclear method of randomization were also performed (n=1141 patients in total).

RESULTS:
Four RCTs (n=587 patients) were eligible for inclusion. No statistically significant differences were present between patients who received a combination of progesterone and estrogen for luteal support when compared with those who received only progesterone, in terms of positive hCG rate (RR:
1.02, 95%

CI:
0.87-1.19), clinical pregnancy rate (RR:
0.94, 95%

CI:
0.78-1.13) and live birth rate (RR:
0.96, 95%

CI:
0.77-1.21) per woman randomized. These results did not materially differ in the sensitivity analyses performed.

CONCLUSIONS:
The currently available evidence suggests that the addition of estrogen to progesterone for luteal phase support does not increase the probability of pregnancy in IVF. However, there is an obvious need for further RCTs that will assess, with more confidence, the effect of estrogen addition to progesterone during the luteal phase on the probability of pregnancy.

Learn Faster Today Improve your study skills

Author information

Author/s: Kolibianakis, E M (EM); Venetis, C A (CA); Papanikolaou, E G (EG); Diedrich, K (K); Tarlatzis, B C (BC); Griesinger, G (G);

Affiliation: Unit for Human Reproduction, 1st Department of Obstetrics and Gynaecology, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Nea Efkarpia Peripheral Road, Thessaloniki 54603, Greece. stratis.kolibianakis(-atsign-)irg.gr

Journal and publication information

Publication Type: Journal Article; Meta-Analysis; Review

Journal: Human reproduction (Oxford, England) (Hum Reprod), published in England. (Language: eng)

Reference: 2008-Jun; vol 23 (issue 6) : pp 1346-54

Dates: Created 2008/05/19; Completed 2008/07/23;

PMID: 18408017, status: MEDLINE (last retrieval date: 11/6/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Drug Therapy, Combination
Estrogens - administration & dosage
Female
Fertilization in Vitro - drug effects
Gonadotrophs
Gonadotropin-Releasing Hormone - administration & dosage; analogs & derivatives

Humans
Luteal Phase - drug effects
Pregnancy - statistics & numerical data
Pregnancy Rate
Progesterone - administration & dosage
Treatment Outcome

Associated Chemicals: Estrogens (0) ; Gonadotropin-Releasing Hormone (33515-09-2) ; Progesterone (57-83-0)

These are the highest related articles currently in the database:

See 100+ related articles.